Clinical trial
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
NCT00491569 · China Medical University Hospital, Other · Completed
Key facts
| NCT number | NCT00491569 |
|---|---|
| Title | Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia |
| Official title | NMDA Enhancers in the Treatment of Schizophrenia: Sarcosine vs. D-Serine |
| Lead sponsor | China Medical University Hospital, Other |
| Collaborators | National Science and Technology Council, Taiwan National Health Research Institutes, Taiwan |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenias, Psychoses, Psychotic Disorders, Schizophrenic Disorders |
| Intervention type | Drug |
| Interventions | Sarcosine and D-serine |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Jun 26, 2007 |
| Last update posted | Jun 26, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: